Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1998 Oct;228(4):536–546. doi: 10.1097/00000658-199810000-00010

The changing spectrum of treatment for variceal bleeding.

L F Rikkers 1
PMCID: PMC1191531  PMID: 9790343

Abstract

OBJECTIVE: The objective of this study was to assess the impact of endoscopic therapy, liver transplantation, and transjugular intrahepatic portosystemic shunt (TIPS) on patient selection and outcome of surgical treatment for this complication of portal hypertension, as reflected in a single surgeon's 18-year experience with operations for variceal hemorrhage. SUMMARY BACKGROUND DATA: Definitive treatment of patients who bleed from portal hypertension has been progressively altered during the past 2 decades during which endoscopic therapy, liver transplantation, and TIPS have successively become available as alternative treatment options to operative portosystemic shunts and devascularization procedures. METHODS: Two hundred sixty-three consecutive patients who were surgically treated for portal hypertensive bleeding between 1978 and 1996 were reviewed retrospectively. Four Eras separated by the dates when endoscopic therapy (January 1981), liver transplantation (July 1985), and TIPS (January 1993) became available in our institution were analyzed. Throughout all four Eras, a selective operative approach, using the distal splenorenal shunt (DSRS), nonselective shunts, and esophagogastric devascularization, was taken. The most common indications for nonselective shunts and esophagogastric devascularization were medically intractable ascites and splanchnic venous thrombosis, respectively. Most other patients received a DSRS. RESULTS: The risk status (Child's class) of patients undergoing surgery progressively improved (p = 0.001) throughout the 4 Eras, whereas the need for emergency surgery declined (p = 0.002). The percentage of nonselective shunts performed decreased because better options to manage acute bleeding episodes (sclerotherapy, TIPS) and advanced liver disease complicated by ascites (liver transplantation, TIPS) became available (p = 0.009). In all Eras, the operative mortality rate was directly related to Child's class (A, 2.7%; B, 7.5%; and C, 26.1 %) (p = 0.001). As more good-risk patients underwent operations for variceal bleeding, the incidence of postoperative encephalopathy decreased (p = 0.015), and long-term survival improved (p = 0.012), especially since liver transplantation became available to salvage patients who developed hepatic failure after a prior surgical procedure. There were no differences between Eras with respect to rebleeding or shunt occlusion. Distal splenorenal shunts (p = 0.004) and nonselective shunts (p = 0.001) were more protective against rebleeding than was esophagogastric devascularization. CONCLUSIONS: The sequential introduction of endoscopic therapy, liver transplantation, and TIPS has resulted in better selection and improved results with respect to quality and length of survival for patients treated surgically for variceal bleeding. Despite these innovations, portosystemic shunts and esophagogastric devascularization remain important and effective options for selected patients with bleeding secondary to portal hypertension.

Full text

PDF
536

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Jin G., Rikkers L. F. Transabdominal esophagogastric devascularization as treatment for variceal hemorrhage. Surgery. 1996 Oct;120(4):641–649. doi: 10.1016/s0039-6060(96)80011-0. [DOI] [PubMed] [Google Scholar]
  2. Kamath P. S., McKusick M. A. Transvenous intrahepatic portosystemic shunts. Gastroenterology. 1996 Dec;111(6):1700–1705. doi: 10.1016/s0016-5085(96)70035-5. [DOI] [PubMed] [Google Scholar]
  3. Langer B., Taylor B. R., Mackenzie D. R., Gilas T., Stone R. M., Blendis L. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology. 1985 Feb;88(2):424–429. doi: 10.1016/0016-5085(85)90502-5. [DOI] [PubMed] [Google Scholar]
  4. Millikan W. J., Jr, Warren W. D., Henderson J. M., Smith R. B., 3rd, Salam A. A., Galambos J. T., Kutner M. H., Keen J. H. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg. 1985 Jun;201(6):712–722. doi: 10.1097/00000658-198506000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Rikkers L. F., Jin G., Burnett D. A., Buchi K. N., Cormier R. A. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg. 1993 Jan;165(1):27–33. doi: 10.1016/s0002-9610(05)80400-3. [DOI] [PubMed] [Google Scholar]
  6. Rikkers L. F., Jin G. Emergency shunt. Role in the present management of variceal bleeding. Arch Surg. 1995 May;130(5):472–477. doi: 10.1001/archsurg.1995.01430050022002. [DOI] [PubMed] [Google Scholar]
  7. Rikkers L. F., Jin G., Langnas A. N., Shaw B. W., Jr Shunt surgery during the era of liver transplantation. Ann Surg. 1997 Jul;226(1):51–57. doi: 10.1097/00000658-199707000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rikkers L. F., Soper N. J., Cormier R. A. Selective operative approach for variceal hemorrhage. Am J Surg. 1984 Jan;147(1):89–96. doi: 10.1016/0002-9610(84)90040-0. [DOI] [PubMed] [Google Scholar]
  9. Rosemurgy A. S., Goode S. E., Zwiebel B. R., Black T. J., Brady P. G. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg. 1996 Sep;224(3):378–386. doi: 10.1097/00000658-199609000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Snady H. The role of sclerotherapy in the treatment of esophageal varices: personal experience and a review of randomized trials. Am J Gastroenterol. 1987 Sep;82(9):813–822. [PubMed] [Google Scholar]
  11. Sugiura M., Futagawa S. A new technique for treating esophageal varices. J Thorac Cardiovasc Surg. 1973 Nov;66(5):677–685. [PubMed] [Google Scholar]
  12. Warren W. D., Salam A. A., Hutson D., Zeppa R. Selective distal splenorenal shunt. Technique and results of operation. Arch Surg. 1974 Mar;108(3):306–314. doi: 10.1001/archsurg.1974.01350270040008. [DOI] [PubMed] [Google Scholar]
  13. Warren W. D., Zeppa R., Fomon J. J. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg. 1967 Sep;166(3):437–455. doi: 10.1097/00000658-196709000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Whipple A. O. The Problem of Portal Hypertension in Relation to the Hepatosplenopathies. Ann Surg. 1945 Oct;122(4):449–475. doi: 10.1097/00000658-194510000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. da Silva L. C., Strauss E., Gayotto L. C., Mies S., Macedo A. L., da Silva A. T., Silva E. F., Lacet C. M., Antonelli R. H., Fermanian J. A randomized trial for the study of the elective surgical treatment of portal hypertension in mansonic schistosomiasis. Ann Surg. 1986 Aug;204(2):148–153. doi: 10.1097/00000658-198608000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES